Researchers analyzed data from 1,541 people to compare two different ways of treating a common stomach bacteria called H. pylori. One group received a 14-day dual therapy of tegoprazan and amoxicillin. The other group received a standard quadruple therapy that included bismuth. The goal was to see if the simpler dual therapy could work as well as the standard treatment.
The results showed that both treatment methods were equally effective at clearing the infection. The study found no significant difference in eradication rates between the two groups. This suggests that the shorter, simpler regimen might be just as effective as the more complex standard treatment.
Safety data also showed that patients on the dual therapy reported fewer side effects and fewer instances of stopping their medication compared to those on the quadruple therapy. While the results are promising, the study noted that reporting for some safety outcomes was not fully standardized. This finding suggests that a simpler dual therapy could be a helpful option for patients who prefer a shorter or easier treatment plan.
